Janus Henderson Group PLC Deciphera Pharmaceuticals, Inc. Transaction History

Janus Henderson Group PLC

$187 Billion
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$13.58 - $17.36 $27 - $34	2 Added 0.01%	26,539 $417,000
Q4 2023 Feb 14, 2024	SELL	$10.11 - $16.54 $909 - $1,488	-90 Reduced 0.34%	26,537 $428,000
Q3 2023 Nov 14, 2023	BUY	$12.46 - $15.48 $261 - $325	21 Added 0.08%	26,627 $338,000
Q2 2023 Aug 14, 2023	BUY	$13.28 - $15.96 $200,554 - $241,027	15,102 Added 131.28%	26,606 $374,000
Q1 2023 May 15, 2023	BUY	$14.26 - $22.1 $164,047 - $254,238	11,504 New	11,504 $177,000
Q4 2021 Feb 14, 2022	SELL	$7.7 - $37.13 $3.14 Million - $15.1 Million	-407,237 Closed	0 $0
Q3 2021 Nov 16, 2021	BUY	$26.46 - $37.15 $2,884 - $4,049	109 Added 0.03%	407,237 $13.8 Million
Q2 2021 Aug 16, 2021	SELL	$32.73 - $47.95 $620,200 - $908,604	-18,949 Reduced 4.45%	407,128 $14.9 Million
Q1 2021 May 17, 2021	BUY	$40.39 - $56.73 $3.69 Million - $5.18 Million	91,239 Added 27.25%	426,077 $19.1 Million
Q4 2020 Feb 16, 2021	SELL	$51.77 - $66.18 $24,228 - $30,972	-468 Reduced 0.14%	334,838 $19.1 Million
Q3 2020 Nov 16, 2020	BUY	$43.8 - $58.16 $13,315 - $17,680	304 Added 0.09%	335,306 $17.2 Million
Q2 2020 Aug 14, 2020	SELL	$37.05 - $65.03 $49,424 - $86,750	-1,334 Reduced 0.4%	335,002 $20 Million
Q1 2020 May 14, 2020	SELL	$33.63 - $69.4 $15.5 Million - $32.1 Million	-461,888 Reduced 57.86%	336,336 $13.8 Million
Q4 2019 Feb 18, 2020	SELL	$31.7 - $69.93 $3.08 Million - $6.79 Million	-97,057 Reduced 10.84%	798,224 $49.7 Million
Q3 2019 Nov 14, 2019	BUY	$19.95 - $38.85 $4.38 Million - $8.53 Million	219,574 Added 32.5%	895,281 $30.4 Million
Q2 2019 Jul 31, 2019	BUY	$21.05 - $26.21 $295,289 - $367,673	14,028 Added 2.12%	675,707 $15.2 Million
Q1 2019 Apr 30, 2019	SELL	$20.65 - $29.55 $842,871 - $1.21 Million	-40,817 Reduced 5.81%	661,679 $15.4 Million
Q4 2018 Feb 06, 2019	BUY	$19.08 - $36.14 $438,801 - $831,147	22,998 Added 3.38%	702,496 $14.7 Million
Q3 2018 Nov 09, 2018	BUY	$33.57 - $42.1 $4.05 Million - $5.08 Million	120,683 Added 21.6%	679,498 $26.3 Million
Q2 2018 Aug 10, 2018	BUY	$20.06 - $44.95 $11.2 Million - $25.1 Million	558,815 New	558,815 $22 Million

Others Institutions Holding DCPH

# of Institutions

Shares Held

293K

Call Options Held

500

Put Options Held

View Full List

About Deciphera Pharmaceuticals, Inc.

Ticker DCPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,822,100
Description
Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...

More about DCPH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Janus Henderson Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Janus Henderson Group PLC with notifications on news.

Account